KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Assets (2016 - 2025)

Historic Return on Assets for BeOne Medicines (ONC) over the last 10 years, with Q3 2025 value amounting to 0.01%.

  • BeOne Medicines' Return on Assets rose 1600.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.11% for FY2024, which is 500.0% up from last year.
  • BeOne Medicines' Return on Assets amounted to 0.01% in Q3 2025, which was up 1600.0% from 0.03% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Return on Assets ranged from a high of 0.01% in Q3 2025 and a low of 0.34% during Q1 2023
  • Over the past 5 years, BeOne Medicines' median Return on Assets value was 0.21% (recorded in 2021), while the average stood at 0.19%.
  • As far as peak fluctuations go, BeOne Medicines' Return on Assets crashed by -1200bps in 2022, and later surged by 2000bps in 2024.
  • Quarter analysis of 5 years shows BeOne Medicines' Return on Assets stood at 0.21% in 2021, then tumbled by -57bps to 0.33% in 2022, then surged by 53bps to 0.16% in 2023, then increased by 29bps to 0.11% in 2024, then soared by 109bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.03% for Q2 2025, and 0.07% during Q1 2025.